BRIEF-Cardiome and Allergan announce Xydalba(tm) licensing agreement in international markets

Thu May 5, 2016 5:35pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 5 (Reuters) - Cardiome Pharma Corp

* Additional terms of agreement were not disclosed.

* Cardiome and allergan announce xydalba(tm) (dalbavancin) licensing agreement in international markets

* Expects to initiate commercial sales of xydalba in its territories as early as 2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)